MétaCan
Menu
Back to cohort
Record W4223938672 · doi:10.1101/2022.03.31.22273208

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis

2022· preprint· en· W4223938672 on OpenAlexaff
Jineta Banerjee, Jan M. Friedman, Laura J. Klesse, Kaleb Yohay, Justin T. Jordan, Scott R. Plotkin, Robert J. Allaway, Jaishri O. Blakeley

Bibliographic record

VenuemedRxiv · 2022
Typepreprint
Languageen
FieldMedicine
TopicNeurofibromatosis and Schwannoma Cases
Canadian institutionsUniversity of British Columbia
FundersYale Center for Clinical Investigation, Yale School of MedicineNational Institute of Diabetes and Digestive and Kidney DiseasesClinical and Translational Science Center, University of New MexicoClinical and Translational Science Institute, Boston UniversitySouth Carolina Clinical and Translational Research Institute, Medical University of South CarolinaCenter for Clinical and Translational Sciences, University of Texas Health Science Center at HoustonInstitute for Integration of Medicine and ScienceCenter for Clinical and Translational Science, Mayo ClinicColorado Clinical and Translational Sciences InstituteCenter for Clinical and Translational Science, University of MassachusettsUniversity of Colorado DenverLeonard M. Miller School of MedicineUniversity of California, IrvineOregon Clinical and Translational Research InstituteWeill Cornell Medical CollegeUniversity of Illinois at Urbana-ChampaignUniversity of Oklahoma Health Sciences CenterNational Institutes of HealthStony Brook UniversityOchsner HealthLouisiana Clinical and Translational Science CenterPenn State Clinical and Translational Science InstituteGeorgia Clinical and Translational Science AllianceChildren's National HospitalUniversity of Arkansas for Medical SciencesVanderbilt University Medical CenterTranslational Research Institute, University of Arkansas for Medical SciencesNorthShore University HealthSystemSouthern California Clinical and Translational Science InstituteUniversity of North Carolina at Chapel HillChildren’s Hospital of Wisconsin Research InstituteUniversity of MiamiUniversity of South CarolinaWest Virginia UniversityCarilion ClinicRutgers, The State University of New JerseyInstitute for Clinical and Translational Research, University of Wisconsin, MadisonPennsylvania State UniversityVanderbilt Institute for Clinical and Translational ResearchUniversity of CincinnatiInstitute of Clinical and Translational SciencesWake Forest Clinical and Translational Science Institute, Wake Forest School of MedicineInstitute for Translational Medicine and TherapeuticsUniversity of Texas Health Science Center at HoustonUniversity of Southern CaliforniaHarvard CatalystUniversity of OklahomaWashington University in St. LouisUniversity of MichiganUniversity of MinnesotaJohns Hopkins UniversityUniversity of WashingtonMichigan Institute for Clinical and Health ResearchUniversity of UtahChildren's Hospital of PhiladelphiaUniversity of PennsylvaniaGeorge Washington UniversityUniversity at BuffaloUniversity of RochesterNorthwestern UniversityVanderbilt UniversityAccelerated Innovation Research Initiative Turning Top Science and Ideas into High-Impact ValuesUniversity of ChicagoVirginia Commonwealth UniversityTulane UniversityBrown UniversityRush UniversityCincinnati Children's Hospital Medical CenterUniversity of Wisconsin-MadisonYale UniversityCenter for Clinical and Translational ResearchEmory UniversityUniversity of Texas Medical BranchWest Virginia Clinical and Translational Science InstituteUniversity of Nebraska Medical CenterChildren's Hospital ColoradoInstitute of Translational Health SciencesTufts Medical CenterFrontiers Clinical and Translational Science Institute, University of KansasUniversity of Texas Health Science Center at San AntonioLoyola University ChicagoWake Forest UniversityOhio State University
KeywordsMedicineCohortCoronavirus disease 2019 (COVID-19)NeurofibromatosisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseasePopulationCohort studyInternal medicinePediatricsPathologyEnvironmental healthInfectious disease (medical specialty)

Abstract

fetched live from OpenAlex

ABSTRACT Purpose People with pre-existing conditions may be more susceptible to severe Coronavirus disease 2019 (COVID-19) when infected by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The relative risk and severity of SARS-CoV-2 infection in people with rare diseases like neurofibromatosis (NF) type 1 (NF1), neurofibromatosis type 2 (NF2), or schwannomatosis (SWN) is unknown. Methods We investigated the proportions of SARS-CoV-2 positive or COVID-19 patients in people with NF1, NF2, or SWN in the National COVID Collaborative Cohort (N3C) electronic health record dataset. Results The cohort sizes in N3C were 2,501 (NF1), 665 (NF2), and 762 (SWN). We compared these to N3C cohorts of other rare disease patients (98 - 9844 individuals) and the general non-NF population of 5.6 million. The site- and age-adjusted proportion of people with NF1, NF2, or SWN who tested positive for SARS-CoV-2 or were COVID-19 patients (collectively termed positive cases ) was not significantly higher than in individuals without NF or other selected rare diseases. There were no severe outcomes reported in the NF2 or SWN cohorts. The proportion of patients experiencing severe outcomes was no greater for people with NF1 than in cohorts with other rare diseases or the general population. Conclusion Having NF1, NF2, or SWN does not appear to increase the risk of being SARS-CoV-2 positive or of being a COVID-19 patient, or of developing severe complications from SARS-CoV-2.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Case report · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.033
Threshold uncertainty score0.066

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.002
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.040
GPT teacher head0.302
Teacher spread0.262 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designCase report
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venuemedRxivSame topicNeurofibromatosis and Schwannoma CasesFrench-language works237,207